To cite this version:M. Klar, M. Bossart, E. Stickeler, I. Brink, M. Orlowska-Volk, et al.. Sentinel lymph node detection in patients with vulvar carcinoma; Feasibility of intraoperative mapping with technetium-99m-labeled nanocolloid. EJSO -European Journal of Surgical Oncology, WB Saunders, 2011, 37 (9) This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
Key words /MeSH terms:Vulvar carcinoma, sentinel lymph node, technetium-99m nanocolloid
Conflict of interestThe authors declare no conflict of interest M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT 3
Abstract
Aims:Sentinel lymph node (SLN) mapping appears to be feasible in patients with primary vulvar cancer. Previous protocols describe the injection of the technetium-99m-nanocolloid at least 3 hours before surgery which involves two invasive procedures for the patient. In this study, we assessed the feasibility, safety, and accuracy of an intraoperative rather than preoperative SLN mapping in patients with primary vulvar cancer.
Methods:Patients with histologically confirmed squamous cell vulvar cancer and clinically FIGO stage Ib disease underwent intraoperative SLN mapping by intradermal injection of the nanocolloid around the tumor. SLN were identified and removed before a complete inguino-femoral lymphnode dissection was performed. Surgical and pathologic data on all patients were prospectively entered into a database.
Results:A SLN procedure was performed in 16 patients; 3 patients received unilateral lymphadenectomy, and 13 women underwent surgery on both groins. In all groins but 4 at least one SLN was clearly identified (detection rate 25/29, 86%). A median number of 2 SLN and 4 non-SLN per groin were removed. 3 of 16 patients (19 %) had metastatic disease in the lymph nodes. There was no false negative SLN result.
Conclusion:Intraoperative SLN detection seems feasible in patients with early stage vulvar cancer. More patients need to be enrolled in this ongoing study before this more convenient technique can be considered safe.